Fact CheckerSign in

NCT07584993Not yet recruiting

Retraining Gait in Parkinson's Disease Via a Personalised App

CuePD in the Home: Retraining Gait in Parkinson's Disease Via a Personalised App

Source: ClinicalTrials.gov · Last updated 13 May 2026

Brief summary (registry, in English)

Introduction Parkinson's disease (PD) limits mobility by worsening gait/walking and increasing fall risk. Falls lead to injuries and reduce confidence in performing everyday tasks. That lowers a person's ability to participate in community activities such as going to the shops or visiting friends, which reduces their quality of life. Development of interventions for gait impairments and falls is a research priority for Parkinson's UK. Understanding gait Traditionally, one approach a physiotherapist may use to try and improve/retrain a person's gait is with an electronic metronome which is a device that "beeps" nearly every second. The physiotherapist sets the metronome beeping, and the person tries to step to each beep. However, success depends on the physio's expertise/experience. Regardless, beeping sounds are described as boring. Smartphone app An app may be the solution. Smartphones have many sensors, meaning they can accurately measure gait but also deliver retraining via music. That is possible by the creation of an "app" that can be downloaded and installed on anyone's smartphone. Research proposal The investigators have developed and validated an app (CuePD) that uses music for gait retraining, to make it more enjoyable by having people listen to their preferred music. The aim for this study is to get people with PD (PwPD) using CuePD in their home and when out walking for 12-weeks to determine: (i) how PwPD use and value CuePD and (ii) CuePD's ability to improve gait to reduce fall risk.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
28 Apr 2026
Start date
1 Aug 2026
Primary completion date
30 Jun 2027
Lead sponsor
Northumbria University
NCT number
NCT07584993

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 1 Aug 2026 to the primary completion date, 30 Jun 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of stroke, traumatic brain injury or other neurological disorders (other than Parkinson's)

Other

  • Non-English speakers
  • Use of any mobility aids e.g., walking stick
  • Unable to comply with the testing protocol or currently participating in another interfering research project.
  • Does not use a smartphone.
  • Body mass index ≥35 (i.e., severe to morbid obesity)

Who the study is looking for

  • Able to walk unaided.
  • Diagnosis of idiopathic Parkinson's.
  • Score ≥21/30 on Montreal Cognitive Assessment (MoCA) which is used to classify non-demented Parkinson's (Parkinson's dementia is \<21/30).
  • Uses a smartphone.

Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Northumbria University
Coordinator of this site? Confirm its status
Newcastle upon TyneUnited KingdomUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.